Skip to main content
AAN.com
Articles
September 1, 2001

Newer risk factors for stroke

September 1, 2001 issue
57 (suppl_2) S31-S34

Abstract

Stroke places a tremendous burden on health resources throughout the world. Improved detection and modification of risk factors could reduce the impact of this disease. Important non-modifiable risk factors for ischemic stroke include age, gender, ethnicity, and heredity. Modifiable risk factors include hypertension, cardiovascular disease, diabetes, hyperlipidemia, asymptomatic carotid stenosis, cigarette smoking, and alcohol abuse. Data from the Northern Manhattan Stroke Study provide new insights into these stroke risk factors.
In this study, African–Americans and Hispanics had a greater incidence of stroke, with almost a twofold increase compared with Caucasians. The protective effect of physical activity and moderate alcohol consumption was confirmed and further established as modifiable risk factors. The independent effects of lipids, apolipoproteins, and lipoprotein were also clarified. High-density lipoprotein was shown to be protective against ischemic stroke (particularly atherosclerotic stroke subtypes). Conversely, lipoprotein-a increased the risk for stroke. The ratio of apolipoprotein b to apolipoprotein a-1 was shown to be associated with carotid atheroma. In addition, newer risk factors, including homocysteine and chronic infection (Chlamydia pneumoniae and periodontal disease), are being studied as predictors of ischemic stroke. With these recent advances in the understanding of risk factors, the ability to detect or modify the risk for ischemic stroke should lead to a substantial reduction in the number of people killed or disabled by stroke each year.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Sacco RL, Boden-Albala B, Gan R, et al. Stroke incidence among white, black and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol . 1998; 147: 259–268.
2.
Sacco RL, Boden-Albala B, Abel G, et al. Race-ethnic disparities in the impact of stroke risk factors: The Northern Manhattan Stroke Study. Stroke 2001 (in press).
3.
Sacco RL, Gan R, Boden-Albala B, et al. Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study. Stroke . 1998; 29: 380–387.
4.
Sacco RL, Elkind M, Boden-Albala B, et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA . 1999; 281: 53–60.
5.
Gorelick PB, Sacco RL, Smith D, et al. Prevention of a first stroke—A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA . 1999; 281: 1112–1120.
6.
Sacco RL, Benson RT, Kargman DE, et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA . 2001; 285: 2729–2735.
7.
Kargman DE, Berglund LF, Boden-Albala B, Lin IF, Paik MC, Sacco RL. Increased stroke risk and lipoprotein (a) in a racially mixed area: the Northern Manhattan Stroke Study. Stroke . 1999; 30: 251.
8.
Jeng JS, Sacco RL, Lui RC, Kargman DE, Boden-Albala B, Berglund L. Association of apolipoproteins to carotid artery atherosclerosis: the Northern Manhattan Stroke Study. Stroke . 1999; 30: 251.
9.
Sacco RL, Roberts JK, Jacobs BS. Homocysteine as a risk factor for ischemic stroke: an epidemiological story in evolution. Neuroepidemiology . 1998; 17: 167–173.
10.
Jacobs BS, Sacco RL, Roberts JK, Chen X, Paik MC, Stabler SP. Race-ethnicity and other environmental determinants of serum homocysteine in northern Manhattan. Stroke . 1998; 29: 277.
11.
Elkind MS, Lin IF, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke. Stroke . 2000; 31: 1521–1525.
12.
Elkind MS, Desvarieux M, Boden-Albala B, et al. Periodontal disease is associated with internal carotid artery plaque thickness. Neurology . 1999; 52: A314.

Information & Authors

Information

Published In

Neurology®
Volume 57Number suppl_2September 1, 2001
Pages: S31-S34
PubMed: 11552052

Publication History

Published online: September 1, 2001
Published in print: September 1, 2001

Authors

Affiliations & Disclosures

Ralph L. Sacco, MS, MD
From the Department of Neurology, Columbia University College of Physicians and Surgeons and the New York Presbyterian Hospital, New York, New York.

Notes

Address correspondence and reprint requests to Dr. Ralph Sacco, Department of Neurology, Neurological Institute, 710 West 168th Street, New York, NY 10032.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Exploring Stroke Risk through Mendelian Randomization: A Comprehensive Study Integrating Genetics and Metabolic Traits in the Korean Population, Biomedicines, 12, 6, (1311), (2024).https://doi.org/10.3390/biomedicines12061311
    Crossref
  2. Risk factors for stroke among anthropometric indices and lipid profiles in the Korean population: a large-scale cross-sectional study, Scientific Reports, 13, 1, (2023).https://doi.org/10.1038/s41598-023-29902-4
    Crossref
  3. Motor sequela of adult and pediatric stroke: Imminent losses and ultimate gains, Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment, (305-346), (2023).https://doi.org/10.1016/B978-0-323-98817-9.00025-9
    Crossref
  4. Implementation of the Gamut of Physiotherapy Maneuvers in Restoration and Normalization of Functional Potencies in a Patient With a Hemorrhagic Stroke: A Case Report, Cureus, (2022).https://doi.org/10.7759/cureus.33035
    Crossref
  5. [Retracted] Effect of Blood Homocysteine on the Outcome of Artificial Insemination in Women with Polycystic Ovary Syndrome, BioMed Research International, 2022, 1, (2022).https://doi.org/10.1155/2022/6311419
    Crossref
  6. Involvements of Hyperhomocysteinemia in Neurological Disorders, Metabolites, 11, 1, (37), (2021).https://doi.org/10.3390/metabo11010037
    Crossref
  7. Plasma-based proteomics reveals lipid metabolic and immunoregulatory dysregulation in post-stroke depression, European Psychiatry, 29, 5, (307-315), (2020).https://doi.org/10.1016/j.eurpsy.2014.03.004
    Crossref
  8. Polymorphism of IL6 receptor gene is associated with ischaemic stroke in patients with metabolic syndrome, Brain Research, 1728, (146594), (2020).https://doi.org/10.1016/j.brainres.2019.146594
    Crossref
  9. Risk Factors, Transient Ischemic Attack and Stroke, (17-34), (2018).https://doi.org/10.1017/9781316161609.003
    Crossref
  10. Epidemiology, Transient Ischemic Attack and Stroke, (1-16), (2018).https://doi.org/10.1017/9781316161609.002
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text HTML

View Full Text HTML

Figures

Tables

Media

Share

Share

Share article link

Share